Tag: Jeune Aesthetics

All

In an early clinical test, a gene-based treatment for aging developed by Jeune Aesthetics showed promising initial results.

Incyte’s sNDA for ruxolitinib cream in children ages 2–11 now faces a new action date to allow additional data review.